These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14670916)

  • 41. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
    Petzer AL; Zandstra PW; Piret JM; Eaves CJ
    J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells.
    Salmon P; Arrighi JF; Piguet V; Chapuis B; Zubler RH; Trono D; Kindler V
    J Gene Med; 2001; 3(4):311-20. PubMed ID: 11529660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
    Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
    Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
    Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    Young JW; Szabolcs P; Moore MA
    J Exp Med; 1995 Oct; 182(4):1111-9. PubMed ID: 7561684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells.
    Zhang R; Xing M; Ji X; Gu L; Yang X; Wang H; Jiang P
    Cytokine; 2010 May; 50(2):195-203. PubMed ID: 20303780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
    Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
    Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
    Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of an early dendritic cell precursor derived from murine lineage-negative hematopoietic progenitor cells.
    Jackson SH; Alicea C; Owens JW; Eigsti CL; Malech HL
    Exp Hematol; 2002 May; 30(5):430-9. PubMed ID: 12031649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expansion and differentiation of cord blood products using a two-step expansion culture.
    McNiece I; Kubegov D; Kerzic P; Shpall EJ; Gross S
    Exp Hematol; 2000 Oct; 28(10):1181-6. PubMed ID: 11027837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinically applicable CD34
    van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
    Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
    Siena S; Di Nicola M; Bregni M; Mortarini R; Anichini A; Lombardi L; Ravagnani F; Parmiani G; Gianni AM
    Exp Hematol; 1995 Dec; 23(14):1463-71. PubMed ID: 8542932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.